Update date
31 Dec 2023
Shareable Research Card
EVOME MEDICAL TECHNOLOGIES INC. Operating Margin
This metric view shows EVOME MEDICAL TECHNOLOGIES INC. operating margin history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q4 2023
- Latest reported value
- -8.8%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Dec 2023
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q4 2023.
- Latest reported value on this page: -8.8%.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Operating Margin
Latest reported operating margin: -8.8%. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q4 2023
SEC-backed company facts were refreshed from filings filed on 16 Apr 2024.
Benchmark Context
How Operating Margin compares with peers
EVOME MEDICAL TECHNOLOGIES INC. sits in the lower half of the current operating margin sample.
Compared with
Compared with 17 companies reporting operating margin in %. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about -0.4x the current sample midpoint. Operating Margin is down about 181% versus the comparable prior period.
- Visible rows currently span reported period ends from 31 Dec 2012 to 31 Mar 2026.
- Nearby companies in this sample: North American Construction Group Ltd. and SRx Health Solutions, Inc..
- Current sample position: rank #12 of 17 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
EVOME MEDICAL TECHNOLOGIES INC.: Operating Margin
Latest period: Q4 2023. Period end: 31 Dec 2023. Units: %. Frequency: quarterly and annual.
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Metric Snapshot
- Latest value
- -8.8%
- Coverage range
- 28 Feb 2021 - 31 Dec 2023
- Fact rows
- 15
What This Metric Tells You
- Shows the reported level of operating margin over 28 Feb 2021 - 31 Dec 2023.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 15 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Operating Margin levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
EVOME MEDICAL TECHNOLOGIES INC. appears at rank #12 in the latest comparison sample.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | GRANITE REAL ESTATE INVESTMENT TRUST (grtuf) | 47% | Year - 31 Dec 2012 | Open GRANITE REAL ESTATE INVESTMENT TRUST Operating Margin |
| 2 | CANADIAN NATIONAL RAILWAY CO (cni) | 40% | Year - 31 Dec 2017 | Open CANADIAN NATIONAL RAILWAY CO Operating Margin |
| 3 | CANADIAN PACIFIC KANSAS CITY LTD/CN (cp) | 37% | Quarter - 31 Mar 2026 | Open CANADIAN PACIFIC KANSAS CITY LTD/CN Operating Margin |
| 4 | Fortis Inc. (fts) | 29% | Year - 31 Dec 2025 | Open Fortis Inc. Operating Margin |
| 5 | HYDRO ONE INC | 25% | Year - 31 Dec 2025 | Open HYDRO ONE INC Operating Margin |
| 6 | Hydro One Ltd (hrnnf) | 25% | Year - 31 Dec 2025 | Open Hydro One Ltd Operating Margin |
Metric Details
- Metric
- Operating Margin (OperatingMargin)
- Taxonomy
- ratio
- Units tracked
- %
- Frequency coverage
- quarterly and annual
- History range
- 28 Feb 2021 - 31 Dec 2023
- Facts on this page
- 15
- Description
- The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
EVOME MEDICAL TECHNOLOGIES INC. Quarterly Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2023 | -8.8% | -5.7% | -181% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -4.3% | -3.1% | -273% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -4.4% | -4.8% | -1159% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -21% | -22% | -9149% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -3.1% | +3.9% | +56% | 01 Sep 2022 | 30 Nov 2022 |
| Q3 2022 | -1.2% | +15% | +93% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | 0.41% | +199% | 01 Apr 2022 | 30 Jun 2022 | |
| Q1 2022 | 0.24% | -3052% | -100% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -7.1% | 01 Sep 2021 | 30 Nov 2021 | ||
| Q3 2021 | -17% | 01 Jun 2021 | 31 Aug 2021 | ||
| Q2 2021 | -198% | 01 Mar 2021 | 31 May 2021 | ||
| Q1 2021 | 3052% | 01 Dec 2020 | 28 Feb 2021 |
EVOME MEDICAL TECHNOLOGIES INC. Annual Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2023 | -8.8% | 01 Jan 2023 | 31 Dec 2023 | ||
| 2021 | -3.3% | -3055% | -100% | 01 Mar 2021 | 28 Feb 2022 |
| 2020 | 3052% | 01 Mar 2020 | 28 Feb 2021 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.